Cargando…

Leydig cell ovarian tumor – clinical case description and literature review

Leydig cell ovarian tumors constitute not only a medical problem for clinicians but also a social problem – which is why women with symptoms of hirsutism relatively quickly contact physicians for medical consultation. Leydig cell ovarian tumor is a rare sex cord-gonadal stromal tumor which constitut...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimek, Mateusz, Radosz, Patrycja, Lemm, Magdalena, Szanecki, Wojciech, Dudek, Aleksandra, Pokładek, Sandra, Piwowarczyk, Maria, Poński, Michał, Cichoń, Bartosz, Kajor, Maciej, Witek, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573336/
https://www.ncbi.nlm.nih.gov/pubmed/33100950
http://dx.doi.org/10.5114/pm.2020.99578
_version_ 1783597420060344320
author Klimek, Mateusz
Radosz, Patrycja
Lemm, Magdalena
Szanecki, Wojciech
Dudek, Aleksandra
Pokładek, Sandra
Piwowarczyk, Maria
Poński, Michał
Cichoń, Bartosz
Kajor, Maciej
Witek, Andrzej
author_facet Klimek, Mateusz
Radosz, Patrycja
Lemm, Magdalena
Szanecki, Wojciech
Dudek, Aleksandra
Pokładek, Sandra
Piwowarczyk, Maria
Poński, Michał
Cichoń, Bartosz
Kajor, Maciej
Witek, Andrzej
author_sort Klimek, Mateusz
collection PubMed
description Leydig cell ovarian tumors constitute not only a medical problem for clinicians but also a social problem – which is why women with symptoms of hirsutism relatively quickly contact physicians for medical consultation. Leydig cell ovarian tumor is a rare sex cord-gonadal stromal tumor which constitutes less than 0.5% of ovarian tumors. These cancers appear at all ages but the majority of the cases concern women in the perimenopause. In the majority of cases (70-85%), the growth is accompanied by androgen secretion, together with virilization and hirsutism. The presence of hormonally active ovarian cancers should be suspected in cases of rapidly growing symptoms of masculinization, especially when the level of free testosterone in the blood exceeds the upper limit for the given age more than three times. In diagnosing postmenopausal hyperandrogenism, it is necessary to take into account hormonally active ovarian tumors, as well as adrenal cancers. It is important to exclude other causes of hyperandrogenism, e.g. endocrinopathies (acromegaly or hypothyroidism), or iatrogenic and idiopathic factors. In order to make the diagnosis and implement the proper treatment method faster, an interdisciplinary team of physicians specializing in endocrinology, gynecology and oncology is crucial. This paper contains a study of two cases concerning Leydig cell ovarian tumors in women of postmenopausal age with symptoms of masculinization and hirsutism.
format Online
Article
Text
id pubmed-7573336
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-75733362020-10-23 Leydig cell ovarian tumor – clinical case description and literature review Klimek, Mateusz Radosz, Patrycja Lemm, Magdalena Szanecki, Wojciech Dudek, Aleksandra Pokładek, Sandra Piwowarczyk, Maria Poński, Michał Cichoń, Bartosz Kajor, Maciej Witek, Andrzej Prz Menopauzalny Case Report Leydig cell ovarian tumors constitute not only a medical problem for clinicians but also a social problem – which is why women with symptoms of hirsutism relatively quickly contact physicians for medical consultation. Leydig cell ovarian tumor is a rare sex cord-gonadal stromal tumor which constitutes less than 0.5% of ovarian tumors. These cancers appear at all ages but the majority of the cases concern women in the perimenopause. In the majority of cases (70-85%), the growth is accompanied by androgen secretion, together with virilization and hirsutism. The presence of hormonally active ovarian cancers should be suspected in cases of rapidly growing symptoms of masculinization, especially when the level of free testosterone in the blood exceeds the upper limit for the given age more than three times. In diagnosing postmenopausal hyperandrogenism, it is necessary to take into account hormonally active ovarian tumors, as well as adrenal cancers. It is important to exclude other causes of hyperandrogenism, e.g. endocrinopathies (acromegaly or hypothyroidism), or iatrogenic and idiopathic factors. In order to make the diagnosis and implement the proper treatment method faster, an interdisciplinary team of physicians specializing in endocrinology, gynecology and oncology is crucial. This paper contains a study of two cases concerning Leydig cell ovarian tumors in women of postmenopausal age with symptoms of masculinization and hirsutism. Termedia Publishing House 2020-10-02 2020-09 /pmc/articles/PMC7573336/ /pubmed/33100950 http://dx.doi.org/10.5114/pm.2020.99578 Text en Copyright © 2020 Termedia http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Case Report
Klimek, Mateusz
Radosz, Patrycja
Lemm, Magdalena
Szanecki, Wojciech
Dudek, Aleksandra
Pokładek, Sandra
Piwowarczyk, Maria
Poński, Michał
Cichoń, Bartosz
Kajor, Maciej
Witek, Andrzej
Leydig cell ovarian tumor – clinical case description and literature review
title Leydig cell ovarian tumor – clinical case description and literature review
title_full Leydig cell ovarian tumor – clinical case description and literature review
title_fullStr Leydig cell ovarian tumor – clinical case description and literature review
title_full_unstemmed Leydig cell ovarian tumor – clinical case description and literature review
title_short Leydig cell ovarian tumor – clinical case description and literature review
title_sort leydig cell ovarian tumor – clinical case description and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573336/
https://www.ncbi.nlm.nih.gov/pubmed/33100950
http://dx.doi.org/10.5114/pm.2020.99578
work_keys_str_mv AT klimekmateusz leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT radoszpatrycja leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT lemmmagdalena leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT szaneckiwojciech leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT dudekaleksandra leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT pokładeksandra leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT piwowarczykmaria leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT ponskimichał leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT cichonbartosz leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT kajormaciej leydigcellovariantumorclinicalcasedescriptionandliteraturereview
AT witekandrzej leydigcellovariantumorclinicalcasedescriptionandliteraturereview